title: Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.
authors.affiliation: Division of Internal Medicine, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Ambrogio
authors.initials: A
authors.lastname: Orlando
authors.affiliation: Division of Internal Medicine, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Rosalba
authors.initials: R
authors.lastname: Orlando
authors.affiliation: Di.Bi.M.I.S., Section of Rheumatology, University of Palermo, Palermo, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Ciccia
authors.affiliation: Division of Internal Medicine, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Renna
authors.affiliation: Department of Pathology, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Aroldo
authors.initials: A
authors.lastname: Rizzo
authors.affiliation: Division of Internal Medicine, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Cottone
authors.affiliation: Division of Internal Medicine, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
authors.forename: Fabio Salvatore
authors.initials: FS
authors.lastname: Macaluso
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D015212:Inflammatory Bowel Diseases; D058566:Sacroiliitis; D025241:Spondylarthritis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C543529:vedolizumab
keywords: Spondyloarthritis; T Cells; Treatment